Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

Background: Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug resistance testing to guide the choice of initial regimen. In addition to optimizing individual patient management, these baseline...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Hofstra, L Marije, Sauvageot, Nicolas, Albert, Jan, Alexiev, Ivailo, Garcia, Federico, Struck, Daniel, Van de Vijver, David AMC, Åsjö, Birgitta, Beshkov, Danail, Coughlan, Suzie, Descamps, Diane, Griskevicius, Algirdas, Hamouda, Osamah, Horban, Andrzej, Van Kasteren, Marjo, Kolupajeva, Tatjana, Kostrikis, Leondios G, Liitsola, Kirsi, Linka, Marek, Mor, Orna, Nielsen, Claus, Otelea, Dan, Paraskevis, Dimitrios, Paredes, Roger, Poljak, Mario, Puchhammer-Stöckl, Elisabeth, Sönnerborg, Anders, Staneková, Danica, Stanojevic, Maja, Van Laethem, Kristel, Zazzi, Maurizio, Zidovec Lepej, Snjezana, Boucher, Charles AB, Schmit, Jean-Claude, Wensing, Annemarie MJ, SPREAD Program, for the, Vandekerckhove, Linos
Format:	Artikel
Sprache:	eng
Schlagworte:	antiretroviral therapy ANTIRETROVIRAL TREATMENT drug resistance EFAVIRENZ ETRAVIRINE Europe HIV-1 INDIVIDUALS INFECTION INTEGRASE Medicine and Health Sciences MUTATIONS PREVALENCE REVERSE-TRANSCRIPTASE INHIBITORS RILPIVIRINE transmission
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!